Status:
UNKNOWN
Multi-dose Ibuprofen Prophylaxis for IUD-insertion
Lead Sponsor:
Orlando VA Medical Center
Conditions:
Pelvic Pain
IUD
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study compares the effectiveness of decreasing pain at time of and day after intrauterine device (IUD) insertion when patients take three doses of Ibuprofen versus three doses of placebo.
Detailed Description
Ibuprofen is commonly used over the counter and prescribed for pain relief such as menstrual cramps. Intrauterine (IUD) insertion can cause pain during and after the insertion. Currently, studies have...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Female
- Able to provide informed consent
- English speaking
- Able to provide telephone and address contact information
- Able and willing to receive HIPAA compliant telephone texts and phone messages
- Stable (the same) address and phone number within the last 6 months.
Exclusion
- Contraindications to IUD insertion (active pelvic infection, current pregnancy)
- Contraindications to NSAIDs (allergy, history of asthma, history of aspirin allergy, history of kidney disease, history of stomach ulcer, history of active GI bleeding, history of liver disease)
- Not undergoing any other concurrent office procedures
Key Trial Info
Start Date :
September 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03868137
Start Date
September 28 2020
End Date
May 1 2022
Last Update
October 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orlando VA Medical Center
Orlando, Florida, United States, 32827